CEA CAR-T / CD38 ADC / Seprehvir

« Back to Pipeline

CEA CAR-T, CD38 ADC, and Seprehvir are our product candidates for the treatment of various cancers

BrainEGFRvIII
Head and NeckERBB family
LungCEA, HER2, MSLN
PleuraFAP, MSLN
BreastCEA, cMET, HER2, MSLN
GastricCEA, HER2
LiverGPC3
ColonCEA
PancreasCEA, MSLN
RenalVEGFR2
OvarianFR, HER2, MSLN, MUC16
ProstatePSMA
SkinGD2, VEGFR2
BoneGD2, HER2
Soft TissueGD2, HER2
NeuralGD2, L1-CAM